Apollon Formularies Dividend
Dividend criteria checks 0/6
Apollon Formularies does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | UK£0 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if APOL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if APOL's dividend payments have been increasing.
Dividend Yield vs Market
Apollon Formularies Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (APOL) | n/a |
Market Bottom 25% (GB) | 2.1% |
Market Top 25% (GB) | 5.8% |
Industry Average (Pharmaceuticals) | 2.4% |
Analyst forecast in 3 Years (APOL) | n/a |
Notable Dividend: Unable to evaluate APOL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate APOL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate APOL's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as APOL has not reported any payouts.